Wolverine Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.41M Sell
88,500
-4,200
-5% -$106K ﹤0.01% 2014
2025
Q2
$2.25M Sell
92,700
-27,200
-23% -$596K ﹤0.01% 1617
2025
Q1
$2.58M Buy
119,900
+78,100
+187% +$1.96M ﹤0.01% 1424
2024
Q4
$991K Sell
41,800
-74,300
-64% -$1.83M ﹤0.01% 2664
2024
Q3
$2.98M Sell
116,100
-18,600
-14% -$474K ﹤0.01% 1408
2024
Q2
$3.16M Sell
134,700
-58,100
-30% -$1.47M ﹤0.01% 1283
2024
Q1
$5.54M Buy
192,800
+100,700
+109% +$3.03M 0.01% 958
2023
Q4
$3.02M Sell
92,100
-2,200
-2% -$59.8K ﹤0.01% 1397
2023
Q3
$2.63M Buy
94,300
+8,300
+10% +$271K ﹤0.01% 1391
2023
Q2
$2.9M Buy
86,000
+70,900
+470% +$2.23M ﹤0.01% 1257
2023
Q1
$433K Sell
15,100
-67,100
-82% -$2.08M ﹤0.01% 2643
2022
Q4
$2.32M Buy
82,200
+17,900
+28% +$568K ﹤0.01% 1298
2022
Q3
$2.12M Sell
64,300
-23,300
-27% -$855K ﹤0.01% 1383
2022
Q2
$2.82M Buy
+87,600
New +$3.06M ﹤0.01% 1133
2022
Q1
Sell
-212,600
Closed -$13.2M 5355
2021
Q4
$13.2M Buy
212,600
+59,900
+39% +$4.14M 0.02% 604
2021
Q3
$11.3M Buy
+152,700
New +$12.8M 0.01% 747
2021
Q2
Sell
-218,700
Closed -$18.5M 5884
2021
Q1
$18.5M Buy
+218,700
New +$21.7M 0.03% 425
2020
Q4
Sell
-7,900
Closed -$507K 4767
2020
Q3
$507K Buy
+7,900
New +$463K ﹤0.01% 2805

Other funds holding ARKG

Wolverine Trading's ARKG Position: Q3 2025 in Review

Wolverine Trading increased its ARK Genomic Revolution ETF (ARKG) stake by 11% in Q3 2025, buying an estimated $102K and bringing the position to 42,447 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

Wolverine Trading first reported a position in ARKG in Q2 2020 and has held it in 19 quarters since. The position peaked at $2.9M in Q1 2024. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • Wolverine Trading held 42,447 shares of ARK Genomic Revolution ETF worth $1.16M as of Q3 2025.
  • Wolverine Trading bought 4,036 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $102K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2745 holding.
  • Wolverine Trading first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 19 quarters since.
  • Wolverine Trading's ARK Genomic Revolution ETF position peaked at $2.9M in Q1 2024.
  • 231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.